Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar Defect

NCT05206682 ↗

Recruiting 94 enrolled Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

RandomizedParallel-groupOpen-labelTreatment

Summary

GnRH-a will be used to postpone period after vaginal repair for Cesarean Section Scar Defect（CSD） patients with adenomyosis which will be compared with CSD patients with adenomyosis who receive transvaginal surgery without GnRH-a, whether delayed period improving the CSD prognosis will be assessed.

Timeline

Start: 2023-05-01
Primary completion: 2027-04-30
Completion: 2027-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Leuprolide	Other / unclassified	—	Subcutaneous

Indications

No indication recorded.